Company Introduction

Biocon Limited is engaged in manufacturing biotechnology products. The Company is an integrated healthcare company engaged in manufacture of biotechnology products for the pharmaceutical sector. The Company is also engaged in research and development in the biotechnology sector.

It operates in two segments: active pharmaceutical ingredients (Pharma) and contract research and manufacturing services (contract research). It offers a range of products from fermentation derived small molecules to recombinant proteins and antibodies. Its products include INSUGEN, insulin analogue Glargine, BASALOG and BioMAb-EGFR for head and neck cancer. The Company?s subsidiaries include Syngene International Limited, Biocon Bio-pharmaceuticals Limited, Biocon Research Limited, Biocon SA, Biocon Sdn Bhd and one joint venture, NeoBiocon FZ LLC.